Quantcast

Latest stroke Stories

2014-04-28 04:21:06

SINGAPORE, April 28, 2014 /PRNewswire/ -- Moleac, a revenue-generating Biopharma company focused on stroke recovery, announced today the appointment of Mr Elmar Schnee as non-executive Chairman of the company. Elmar Schnee succeeds to Prof Marc Vasseur, co-founder of Moleac and first Chairman (2004-2013). Mr. Schnee was from 2011 - 2013 CEO of Cardiorentis in Zug, Switzerland. Prior to this, Mr. Schnee was General Partner and member of the Executive Board of Merck KGaA, responsible...

2014-04-26 23:03:01

Nobles Medical Technologies II, Inc. (NMT2) today announced that it has officially launched sales in Sweden for its NobleStitch EL PFO Closure System. NMT2 launched sales initially in Germany and the UK and will now be expanding this month into Sweden. Fountain Valley, California (PRWEB) April 26, 2014 Following a successful meeting at the Congress of Structural Interventions (CSI) congress in Frankfurt last June NMT2 received significant inquiries to bring its PFO technology to new...

2014-04-25 23:09:46

Nobles Medical Technologies II, Inc. (NMT2) today announced that it has received recertification of its ISO13485 and EN-ISO 14971 after a successful audit by its European notified body. This successful audit recertifies NMT2 to manufacture and sell its PFO Closure and suture products throughout the European Union. Fountain Valley, California (PRWEB) April 25, 2014 Prof. Dr. Anthony Nobles, CEO of NMT2 commented, “Our record in Regulatory Affairs and Quality Assurance worldwide shows our...

2014-04-24 23:13:46

Androderm Lawsuit Joins The More Than 30 Testosterone Treatment Lawsuits Currently Pending in Federal Courts Involving Testosterone Therapy Drugs Columbus, OH (PRWEB) April 24, 2014 An Androderm lawsuit has been recently been filed by an Albany County, New York man. Wright & Schulte LLC has learned the plaintiff in this testosterone treatment lawsuit is seeking compensation for a stroke he alleges he suffered after using the testosterone treatment drug Androderm. This Androderm...

2014-04-24 23:09:00

UVA's stroke program has received the highest quality award from the American Heart Association. Charlottesville,VA (PRWEB) April 24, 2014 The American Heart Association has recognized the quality and safety of UVA’s stroke care with two awards. UVA received both the Get With The Guidelines®-Stroke Gold-Plus Quality Achievement Award and made the Target: Stroke Honor Roll. The awards represent the highest level of stroke quality recognition offered by the AHA. “We couldn’t...

2014-04-23 09:46:08

Study finds jump in patients receiving clot-busting drug within 'golden hour' Administering a clot-dissolving drug to stroke victims quickly — ideally within the first 60 minutes after they arrive at a hospital emergency room — is crucial to saving their lives, preserving their brain function and reducing disability. Given intravenously, tPA (tissue plasminogen activator) is currently the only Food and Drug Administration–approved therapy shown to improve outcomes for patients...

2014-04-23 09:40:01

Using an ambulance that included a computed tomography (CT) scanner, point-of-care laboratory, telemedicine connection and a specialized prehospital stroke team resulted in decreased time to treatment for ischemic stroke, according to a study in the April 23/30 issue of JAMA, a neurology theme issue. Stroke is a leading cause of death and disability. In acute ischemic stroke, thrombolysis (dissolving of blood clots) using intravenous tissue plasminogen activator (tPA) is the treatment of...

2014-04-23 09:38:28

The majority of adults surveyed indicated they would want administration of clot-dissolving medications if incapacitated by a stroke, a finding that supports clinicians' use of this treatment if patient surrogates are not available to provide consent, according to a study in the April 23/30 issue of JAMA, a neurology theme issue. "In life-threatening emergencies involving incapacitated patients without surrogates, clinicians may intervene without obtaining informed consent, applying the...

2014-04-23 09:35:06

Patients with arteriovenous malformations (abnormal connection between arteries and veins) in the brain that have not ruptured had a lower risk of stroke or death for up to 12 years if they received conservative management of the condition compared to an interventional treatment, according to a study in the April 23/30 issue of JAMA, a neurology theme issue. Interventional treatment for brain arteriovenous malformations (bAVMs) with procedures such as neurosurgical excision, endovascular...

2014-04-23 09:33:59

In a study that included more than 71,000 stroke patients, implementation of a quality initiative was associated with improvement in the time to treatment and a lower risk of in-hospital death, intracranial hemorrhage (bleeding in the brain), and an increase in the portion of patients discharged to their home, according to the study appearing in the April 23/30 issue of JAMA, a neurology theme issue. Intravenous tissue plasminogen activator (tPA; an enzyme that helps dissolve clots)...


Latest stroke Reference Libraries

Stroke
2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »
Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related